The trajectory of Zespri, marked by breakthrough successes, was not without its profound tests, necessitating significant transformation to ensure its continued viability and leadership. The most formidable challenge arrived in 2010 with the discovery of Pseudomonas syringae pv. actinidiae (PSA), a highly destructive bacterial vine disease, in New Zealand kiwifruit orchards. This pathogen posed an existential threat, particularly to the commercially successful Hort16A (Gold) variety, which had become Zespri’s premium offering, accounting for approximately 30% of New Zealand's kiwifruit production by volume and a significant portion of its revenue. Hort16A proved highly susceptible to PSA, exhibiting rapid vine death and severe fruit damage. The outbreak led to widespread vine mortality, rendering vast areas of orchards unproductive and causing immense financial hardship for thousands of growers across the Bay of Plenty and other growing regions, marking a period of intense crisis for the entire industry.
The immediate impact of PSA was devastating, rapidly escalating from initial detection to a full-blown epidemic. Industry records indicate a rapid decline in Hort16A production, with the disease first identified in November 2010 and quickly spreading, necessitating the removal of entire orchards and a massive replanting effort. Within two years, an estimated 80% of Hort16A orchards were either significantly affected or completely lost. The economic cost to the New Zealand kiwifruit industry was projected to be in the order of NZD $885 million over five years, encompassing lost production, removal costs, replanting expenses, and reduced asset values. Zespri, in its capacity as the single-desk marketer and industry leader, spearheaded the response. This involved coordinating urgent research efforts through newly established entities like Kiwifruit Vine Health (KVH) to understand the pathogen’s epidemiology and develop effective management protocols. Concurrently, Zespri provided extensive support and guidance to growers for vine management, orchard hygiene, and the complex process of vine removal and replanting. Furthermore, it managed the profound financial implications, including assisting growers in navigating substantial losses and working with financial institutions and the government to provide relief. The crisis forced an urgent strategic pivot, accelerating existing research into more PSA-tolerant varieties and demanding an unprecedented level of cooperation across the industry to survive.
A key element of Zespri’s adaptation was the accelerated development and commercialization of a new golden kiwifruit variety, Zesy002, later branded as Zespri SunGold Kiwifruit. Fortuitously, Zesy002 had been identified years earlier as part of Zespri’s ongoing cultivar development program (co-funded with Plant & Food Research), long before PSA became a threat. This foresight proved critical. The variety was selected for its natural tolerance to PSA, combined with excellent consumer attributes such as a consistently sweet taste profile, smooth skin, and extended shelf life, which resonated strongly with global markets. The transition from Hort16A to Zesy002 involved a monumental, industry-wide replanting program. This required substantial investment, with growers often grafting existing healthy rootstock or removing old vines entirely and replanting, a process that could take several years to yield commercial fruit. Zespri played a central role in facilitating this by managing the intellectual property licensing for Zesy002, allocating SunGold licenses to growers, and collaboratively investing in the new variety’s global marketing and supply chain development. This period of intense change demonstrated the unique resilience inherent in Zespri's cooperative model, where collective action, shared risk-taking, and centralized strategic decision-making facilitated a rapid and coordinated response to an unforeseen biological threat, pooling resources to overcome individual financial hurdles.
Beyond managing the immediate PSA crisis, Zespri embarked on strategic shifts to diversify its global supply base, mitigating future risks associated with reliance on a single growing region. While New Zealand remains the primary production hub, accounting for approximately 80% of Zespri's total volume, the company significantly expanded its offshore growing programs. This included establishing or deepening partnerships in key regions such as Italy, France, Greece, Korea, and Japan. This strategy, initiated before PSA as a means to provide year-round supply and manage seasonal climatic variations, was significantly accelerated by the crisis. By cultivating fruit in both Northern and Southern Hemisphere locations, Zespri transformed its supply chain into a truly global one, ensuring continuity of supply and market presence across all twelve months of the year. This diversification not only reduced vulnerability to localized climatic events or diseases but also allowed Zespri to meet consistent consumer demand, build year-round brand loyalty, and optimize logistical networks, thereby enhancing its competitive position in various international markets.
Throughout these transformations, Zespri also faced continuous scrutiny and challenges to its single-desk marketing model, both domestically and internationally. Critics, including some independent growers and external market players, argued that the model limited competition, potentially stifled innovation outside of Zespri's purview, and could disadvantage individual growers seeking alternative market access. However, Zespri and the majority of its growers consistently argued that the single-desk system was crucial for maintaining stringent quality standards, preventing debilitating price wars among New Zealand exporters, and enabling the significant, long-term investments in brand building, market development, and R&D that benefited the entire industry. The collective bargaining power and unified marketing approach afforded by the single-desk model were particularly vital during the PSA crisis, enabling a coordinated industry-wide recovery effort. The New Zealand Kiwifruit Act 2004, which legislatively underpins the single-desk, has undergone periodic reviews by government bodies, including the Ministry for Primary Industries, which have consistently affirmed the model’s net benefits to the New Zealand economy and growers, citing its role in maximizing orchard gate returns and fostering industry stability.
Internal challenges during this transformative period included managing the immense financial burden of the PSA recovery, which involved significant capital expenditure for replanting and research, alongside managing decreased revenue from Hort16A. Maintaining grower morale amidst widespread vine removal, financial stress, and the uncertainty of a new variety’s success was paramount. Zespri had to scale its operations to accommodate a rapidly growing global footprint, necessitating the expansion of its technical teams (e.g., horticulturists, supply chain specialists) and market development teams across multiple continents. This included refining its global logistics networks, improving data analytics capabilities for supply chain optimization, and strengthening its stakeholder communication strategies to ensure transparency, build trust, and maintain alignment with its diverse grower base. The company's organizational structure adapted to manage parallel supply chains (New Zealand and offshore), complex licensing agreements, and intensified R&D into new varieties and disease management. The experience of navigating the PSA crisis ultimately forged a more resilient and strategically agile organization, deeply attuned to both horticultural science and global market dynamics, with enhanced risk management capabilities.
By the mid-2010s, Zespri had not only recovered from the PSA devastation but had emerged significantly stronger. The remarkable success of SunGold Kiwifruit, which quickly gained market acceptance and premium pricing, became the primary driver of this resurgence. Zespri’s revenue streams rebounded strongly; by 2017, the company reported record revenue, surpassing pre-PSA levels, with SunGold volume steadily increasing. Its global brand equity further solidified, and Zespri maintained its position as the world's leading kiwifruit marketer. This period of intense transformation underscored Zespri’s capacity for rapid innovation, its strategic foresight in developing new varieties, and the enduring strength of its cooperative structure in navigating unprecedented biological and commercial adversity. The comprehensive lessons learned from this challenging era, particularly in risk management, strategic investment in R&D, and the critical importance of a diversified global supply chain, provided a robust framework for managing future growth and ensuring the long-term sustainability and profitability of the New Zealand kiwifruit industry.